Cadila Healthcare Archives

Zydus Lifesciences’ Generic Drug Mirabegron for Overactive Bladder Gets USFDA Nod

Aniruddh ShrivastavaOctober 3, 2022October 3, 2022

by Aniruddh ShrivastavaOctober 3, 2022October 3, 202201325

On Monday, Zydus Lifesciences said it received the USFDA’s (United States Food and Drug Administration) final nod to market its version of Mirabegron extended-release tablets...

MARKETS

Pharma Stock Shows Upto 11% Upside

Neha VermaJune 30, 2021

by Neha VermaJune 30, 202101357

Led by gains in Divi’s Labs, Sun Pharma, Cadila Healthcare, and Dr Reddy’s Laboratories, the Nifty Pharma pack was trading marginally higher in Wednesday’s trade,...

INDIA

Zydus Seeks DCGI Nod to Undertake Clinical Trials for Monoclonal Antibodies Cocktail

Neha VermaMay 27, 2021May 27, 2021

by Neha VermaMay 27, 2021May 27, 202101201

Zydus has announced biological therapy ZRC-3308, used to treat mild COVID-19. The pharmaceutical company now seeks DCGI (Drugs Controller General of India) nod to undertake...

STARTUPS

Zydus Cadila Launches Breast Cancer Treatment Drug Ujvira

Neha VermaMay 24, 2021May 24, 2021

by Neha VermaMay 24, 2021May 24, 202101546

Zydus Cadila has launched Ujvira and has used drugs for the treatment of breast cancer. The company has launched Trastuzumab Emtansine, the first antibody-drug conjugate...

BUSINESS

Nifty Pharma Climbs 3% After RBI Announces Liquidity

Neha VermaMay 5, 2021May 5, 2021

by Neha VermaMay 5, 2021May 5, 202101214

Nifty Pharma stocks were in fast lane on Wednesday tracking all market clues. The performance in pharma stocks comes after when the RBI Governor Shaktikanta...

STARTUPS

India’s Top Pharma Majors in Talks to Buy Pharmarack

NileshMarch 31, 2021April 8, 2021

by NileshMarch 31, 2021April 8, 202102233

India’s top pharmaceutical majors, including Sun Pharma, Cadila Healthcare, Lupin, and Torrent Pharma, are in talks to acquire business-to-business healthcare platform Pharmarack, according to multiple...

Latest News

Medicine Sales Rise 14.5% in Nov, Pharma Firms Lead Growth

adminDecember 9, 2019

by adminDecember 9, 20190734

As per the research firm, the sales were ‘one of the best growths seen in more than 32 months’, and attributed it to the weak...

Latest News

Pharma Shares Decline, Dr Reddy’s Lab down by 1%

adminJuly 17, 2019

by adminJuly 17, 201901101

On Wednesday’s morning session, Pharma shares were trading lower with their sectoral index trading lower. Shares of Cadila Healthcare down by 0.47 per cent, Dr...

Latest News

Zydus Cadila Receives Approval From US FDA

adminOctober 3, 2018

by adminOctober 3, 20180874

Drug firm Zydus Cadila has said that it has received final nod from the United States Food and Drug Administration (USFDA) to market generic Desoximetasone...

Latest News

Cadila Healthcare receives approval from USFDA for Zolmitriptan tablets

adminJuly 12, 2018

by adminJuly 12, 20180892

Cadila Healthcare has received final approval for Zolmitriptan tablets USP, from the USFDA. The company has received final approval to market Zolmitriptan Tablets, 2.5 mg and 5 mg,...

Download Unicorn Signals App

EquityPandit

Tag : Cadila Healthcare

Zydus Lifesciences’ Generic Drug Mirabegron for Overactive Bladder Gets USFDA Nod

Pharma Stock Shows Upto 11% Upside

Zydus Seeks DCGI Nod to Undertake Clinical Trials for Monoclonal Antibodies Cocktail

Zydus Cadila Launches Breast Cancer Treatment Drug Ujvira

Nifty Pharma Climbs 3% After RBI Announces Liquidity

India’s Top Pharma Majors in Talks to Buy Pharmarack

Medicine Sales Rise 14.5% in Nov, Pharma Firms Lead Growth

Pharma Shares Decline, Dr Reddy’s Lab down by 1%

Zydus Cadila Receives Approval From US FDA

Cadila Healthcare receives approval from USFDA for Zolmitriptan tablets

EquityPandit